BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25726183)

  • 1. Expression of podoplanin in the invasion front of oral squamous cell carcinoma is not prognostic for survival.
    de Vicente JC; Santamarta TR; Rodrigo JP; García-Pedrero JM; Allonca E; Blanco-Lorenzo V
    Virchows Arch; 2015 May; 466(5):549-58. PubMed ID: 25726183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding patterns of invasion: a novel approach to assessment of podoplanin expression in the prediction of lymph node metastasis in oral squamous cell carcinoma.
    Sharma A; Boaz K; Natarajan S
    Histopathology; 2018 Mar; 72(4):672-678. PubMed ID: 29023936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podoplanin and VEGF-C immunoexpression in oral squamous cell carcinomas: prognostic significance.
    dos Santos Almeida A; Oliveira DT; Pereira MC; Faustino SE; Nonogaki S; Carvalho AL; Kowalski LP
    Anticancer Res; 2013 Sep; 33(9):3969-76. PubMed ID: 24023336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of podoplanin expression in oral squamous cell carcinoma--a regression model auxiliary to UICC classification.
    Seki S; Fujiwara M; Matsuura M; Fujita S; Ikeda H; Umeda M; Asahina I; Ikeda T
    Pathol Oncol Res; 2014 Jul; 20(3):521-8. PubMed ID: 24281769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moesin expression by tumor cells is an unfavorable prognostic biomarker for oral cancer.
    Barros FBA; Assao A; Garcia NG; Nonogaki S; Carvalho AL; Soares FA; Kowalski LP; Oliveira DT
    BMC Cancer; 2018 Jan; 18(1):53. PubMed ID: 29310601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podoplanin and E-cadherin expression in preoperative incisional biopsies of oral squamous cell carcinoma is related to lymph node metastases.
    Foschini MP; Leonardi E; Eusebi LH; Farnedi A; Poli T; Tarsitano A; Cocchi R; Marchetti C; Gentile L; Sesenna E; Marucci G; Montebugnoli L
    Int J Surg Pathol; 2013 Apr; 21(2):133-41. PubMed ID: 23349470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordant podoplanin expression in cancer-associated fibroblasts and tumor cells is an adverse prognostic factor in esophageal squamous cell carcinoma.
    Chuang WY; Yeh CJ; Chao YK; Liu YH; Chang YS; Tseng CK; Chang HK; Wan YL; Hsueh C
    Int J Clin Exp Pathol; 2014; 7(8):4847-56. PubMed ID: 25197355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of podoplanin in potentially malignant disorders and oral squamous cell carcinoma and its correlation with lymphangiogenesis.
    Parhar S; Kaur H; Vashist A; Verma S
    Indian J Cancer; 2015; 52(4):617-22. PubMed ID: 26960495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podoplanin expression in tumor-free resection margins of oral squamous cell carcinomas: an immunohistochemical and fractal analysis study.
    Margaritescu C; Raica M; Pirici D; Simionescu C; Mogoanta L; Stinga AC; Stinga AS; Ribatti D
    Histol Histopathol; 2010 Jun; 25(6):701-11. PubMed ID: 20376776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma.
    Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Takamori K; Igawa K; Yoshida M; Fukuyama H; Takahashi T; Sakoda S
    J Oral Pathol Med; 2006 May; 35(5):301-6. PubMed ID: 16630294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
    Kang Y; Zhang Y; Sun Y
    Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
    Hwang YS; Ahn SY; Moon S; Zheng Z; Cha IH; Kim J; Zhang X
    Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines.
    Ohta M; Abe A; Ohno F; Hasegawa Y; Tanaka H; Maseki S; Kondo E; Kurita K; Nakanishi H
    Oral Oncol; 2013 Jan; 49(1):20-6. PubMed ID: 22840788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical Expression of Podoplanin in Clinical Variants of Oral Leukoplakia and Its Correlation With Epithelial Dysplasia.
    D'souza B; Nayak R; Kotrashetti VS
    Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):132-139. PubMed ID: 27153448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of podoplanin is associated with poor outcome in cutaneous squamous cell carcinoma.
    Cañueto J; Cardeñoso-Álvarez E; Cosano-Quero A; Santos-Briz Á; Fernández-López E; Pérez-Losada J; Román-Curto C
    J Cutan Pathol; 2017 Feb; 44(2):144-151. PubMed ID: 27859466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic Vascular Density, the Expression of Podoplanin and Tumor Budding in Oral Squamous Cell Carcinoma.
    de Assis EM; Rodrigues M; Vieira JC; Pascoaloti MIM; Junior HM; Souto GR; Souza PEA; Horta MCR
    Head Neck Pathol; 2023 Jun; 17(2):371-382. PubMed ID: 36480090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunohistochemical characterization of MMP-2, MMP-10, TIMP-1, TIMP-2, and podoplanin in oral squamous cell carcinoma.
    Mashhadiabbas F; Mahjour F; Mahjour SB; Fereidooni F; Hosseini FS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Aug; 114(2):240-50. PubMed ID: 22769410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma.
    Ni YH; Ding L; Zhang DY; Hou YY; Huang X; Hu Q
    Histopathology; 2015 Nov; 67(5):730-9. PubMed ID: 25828894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx.
    Huber GF; Fritzsche FR; Züllig L; Storz M; Graf N; Haerle SK; Jochum W; Stoeckli SJ; Moch H
    Int J Cancer; 2011 Sep; 129(6):1404-9. PubMed ID: 21105028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The level and clinical significance of 5-hydroxymethylcytosine in oral squamous cell carcinoma: An immunohistochemical study in 95 patients.
    Wang Y; Hu H; Wang Q; Li Z; Zhu Y; Zhang W; Wang Y; Jiang H; Cheng J
    Pathol Res Pract; 2017 Aug; 213(8):969-974. PubMed ID: 28554766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.